Disease Overview：Male Infertility（MI）
Male infertility is a clinical condition defined by the inability of a male partner to achieve pregnancy with a fertile female partner after 12 months of regular, unprotected intercourse. It affects approximately 7% of men globally and may stem from pretesticular (e.g., hypothalamic-pituitary dysfunction), testicular (e.g., varicocele, Klinefelter syndrome, cryptorchidism), or post-testicular causes (e.g., obstructive azoospermia, ejaculatory disorders). Diagnostic evaluation typically includes semen analysis, hormonal profiling (FSH, LH, testosterone, prolactin), scrotal ultrasound, genetic testing (karyotype, Y-chromosome microdeletion), and, when indicated, testicular sperm extraction (TESE) or micro-TESE. Treatment modalities range from lifestyle modification and pharmacotherapy (e.g., clomiphene citrate, gonadotropins) to surgical interventions (varicocelectomy, vasovasostomy) and assisted reproductive technologies (ART), including intrauterine insemination (IUI) and in vitro fertilization with intracytoplasmic sperm injection (IVF-ICSI).
China offers distinct advantages for international patients seeking evidence-based male infertility care. The country hosts nationally accredited Reproductive Medicine Centers—many affiliated with top-tier academic hospitals—staffed by physicians trained in reproductive endocrinology and urology, with extensive experience managing complex cases such as non-obstructive azoospermia and recurrent IVF failure. Advanced technologies—including high-magnification microsurgical sperm retrieval, time-lapse embryo imaging, and next-generation sequencing for genetic diagnosis—are widely available and routinely integrated into clinical pathways. Success rates for ICSI using surgically retrieved sperm align with international benchmarks, with cumulative live birth rates exceeding 45% per initiated cycle in optimized patient cohorts. Crucially, treatment costs in China are typically 40–60% lower than in the US, UK, or Western Europe, without compromising regulatory standards or clinical rigor. As a dedicated medical tourism agency, we facilitate seamless access to these services: coordinating appointments with certified specialists, verifying hospital accreditation, providing itemized, transparent pricing in advance, arranging visa support and local logistics, and offering multilingual clinical coordination throughout diagnosis, treatment, and follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Male Infertility (Andrology/Reproductive Medicine)
Non-Surgical & Conservative Management
*Target criteria:* Hormonal imbalances (e.g., low testosterone, hyperprolactinemia), mild oligozoospermia (<15 million/mL), varicocele Grade I–II without palpable mass, lifestyle-related infertility.
- •Initial Diagnostic Workup (mandatory before treatment):
- Serum hormone panel (FSH, LH, testosterone, prolactin, estradiol): $75–$95 - Scrotal Doppler ultrasound: $85–$110 - Genetic screening (karyotype + Y-microdeletion) if severe oligo/azoospermia: $220–$280
- •Pharmacotherapy (3–6 months):
- hCG injections (1,000 IU twice weekly): $180–$240/course - Antioxidant regimen (vitamin E, C, zinc, L-carnitine): $35–$55/month - Cabergoline (for hyperprolactinemia): $20–$30/month
Surgical & Procedural Interventions
*Eligibility:* Palpable varicocele (Grade II–III), obstructive azoospermia (e.g., post-vasectomy, CBAVD), testicular sperm extraction candidates.
- •Preoperative Workup:
- Sperm DNA fragmentation test (if indicated): $140–$180
- •Procedures:
- Percutaneous embolization (unilateral): $1,200–$1,600 - Micro-TESE (microdissection testicular sperm extraction): $2,800–$3,600 - Vasovasostomy (microsurgical reversal): $2,100–$2,750 - Epididymovasostomy: $2,400–$3,100
Special/Complex Condition Management
- •Non-obstructive azoospermia (NOA) with failed micro-TESE: Hormonal priming + repeat micro-TESE or donor sperm IUI/IVF: $3,200–$4,100
- •Genetic infertility (e.g., Klinefelter syndrome): Testosterone replacement + IVF/ICSI with PGT-A: $4,800–$6,300 (includes sperm retrieval, IVF cycle, embryo biopsy)
- •Post-chemotherapy infertility: Cryopreserved sperm use + ICSI: $3,500–$4,400 (thawing, ICSI, embryo transfer)
Quick Selection Guide
- •Age <35, mild oligozoospermia, budget <$500: Start with diagnostics + clomiphene + antioxidants ($350–$450 total)
- •Age 35–42, palpable varicocele, moderate teratozoospermia: Microsurgical varicocelectomy + post-op semen reanalysis ($1,700–$2,200)
- •Azoospermia, normal FSH/testosterone: Micro-TESE + immediate ICSI ($5,200–$6,800)
- •Comorbid obesity/diabetes: Lifestyle intervention + metformin + hormonal optimization ($280–$400 initial 3 months)
- •Severe NOA + elevated FSH (>15 IU/L): Early genetic testing + donor sperm pathway ($2,600–$3,400 for donor IUI ×3 cycles)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Male Infertility Medical Vacation Packages
Curated transparent all-inclusive packages combining Male Infertility treatment with China top medical destinations:
